Share this article
Share this article
ResearchAndMarkets.com s offering.
Amid the COVID-19 crisis, the global market for CBD Nutraceuticals estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$16.4 Billion by 2027, growing at a CAGR of 17.7% over the analysis period 2020-2027.
CBD Tinctures, one of the segments analyzed in the report, is projected to record a 16.1% CAGR and reach US$5.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Capsules & Softgels segment is readjusted to a revised 19.7% CAGR for the next 7-year period.
Search jobs 06-May-2021 CBD Oil Market Size, Share, Trends, Global Industry Trends, Growth, Top Key Players and 2027 Forecast Research Report
DBMR announces the release of the “Global CBD Oil Market Size, Share, Growth, Industry Trends and Forecast 2027. The Global CBD Oil Market report provides an in-depth analysis of the, drivers & opportunities, market size & estimations, competitive landscape, top investment pockets, top winning strategies and changing market trends. The market report also focuses on CBD Oil market share, size, trends and global major leading industry players with information. Research report covers each geographical region based on the growth rate, macroeconomic parameters, and consumer buying patterns, demand and present scenarios in the CBD Oil industry. The report on the CBD Oil market is an exclusive and deep study that delivers a comprehensive overview of the industry contains the recent trends and future
CBD brands faced financial headwinds in 2020 2020 was a brutal year for many CBD brands, based on their financial results, yet sales in the broader category continued to grow.
A hemp-based CBD industry that was once searing hot hit the skids in 2020 amid cutthroat competition, regulatory uncertainty and a global pandemic that disrupted retail operations.
The financial results of many public companies selling CBD were dismal, especially when contrasted with several years of heady growth.
“2020 proved to be a very challenging year for the company and our industry, predominantly due to the impact of COVID-19,” CV Sciences Inc. CEO Joseph Dowling acknowledged in a fourth-quarter earnings call with analysts. “The year-long COVID-19 pandemic created significant headwinds for our retail customers, intensified competitive pressures and extended the regulatory uncertainty.”
/Legal Marijuana Market 2021 by Historical Data, Financial Reports of Key Industry Players and Industry Journals 2027
Legal Marijuana Market 2021 by Historical Data, Financial Reports of Key Industry Players and Industry Journals 2027 19
The global Legal Marijuana Market research report, published by Data Bridge Market Research, introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. This provides features a basic overview of the market including definitions, applications, classifications, industry chain structure, and forecast during 2021 to 2028 time-periods. Further, the market fundamentals, in Legal Marijuana industry development, regional market, and market participants are highlighted in the report. The report has added comprehensive segmentation with respect to the component, functionality, end user, and geography. The impact of the COVID-19, and also forecasts its recovery post-COVID
The global CBD nutraceuticals market size is expected to reach USD 19.25 billion by 2028
The demand for CBD nutraceuticals is expected to increase during the forecast period owing to increasing obesity and related disorders, growing health consciousness, and greater awareness regarding benefits associated with cannabidiol nutraceuticals. The legalization of the U.S. Farm Bill in late 2018 leading to the commercialization of hemp-derived products, increasing disposable income of consumers, and growing shift towards health and wellness products has significantly increased the demand for cannabidiol nutraceuticals.
In March 2018, MGC Pharma expanded its product portfolio through the introduction of cannabis and hemp-enhanced nutraceutical products. The company launched several vegan products including supplements and food-grade products under its new line, MGC Nutraceuticals. Its new offerings include capsules, water-soluble cannabinoids, and ready-to-drink products containing high-